AII
REGN icon

AGF Investments Inc’s Regeneron Pharmaceuticals REGN Stock Holding History

AGF Investments Inc’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-981
Closed -$620K – 659
2021
Q4 		$620K Sell
981
-467
-32% -$287K ﹤0.01% 472
2021
Q3 		$876K Buy
1,448
+357
+33% +$222K 0.01% 432
2021
Q2 		$609K Buy
1,091
+719
+193% +$364K ﹤0.01% 467
2021
Q1 		$176K Buy
372
+26
+8% +$12.7K ﹤0.01% 654
2020
Q4 		$167K Sell
346
-227
-40% -$123K ﹤0.01% 666
2020
Q3 		$321K Sell
573
-767
-57% -$465K ﹤0.01% 569
2020
Q2 		$836K Sell
1,340
-322
-19% -$183K 0.01% 373
2020
Q1 		$812K Buy
+1,662
New +$686K 0.01% 346
2017
Q4 		– Sell
-68,486
Closed -$30.6M – 397
2017
Q3 		$30.6M Buy
+68,486
New +$32.6M 0.33% 92
2016
Q2 		– Sell
-99,502
Closed -$35.8M – 488
2016
Q1 		$35.8M Buy
99,502
+4,888
+5% +$2.01M 0.43% 83
2015
Q4 		$51.4M Sell
94,614
-1,503
-2% -$814K 0.63% 58
2015
Q3 		$44.8M Sell
96,117
-63,144
-40% -$33.9M 0.56% 66
2015
Q2 		$81.2M Sell
159,261
-6,316
-4% -$3.08M 0.88% 32
2015
Q1 		$74.7M Sell
165,577
-6,968
-4% -$2.95M 0.81% 37
2014
Q4 		$70.7M Buy
172,545
+54,387
+46% +$21.4M 0.76% 46
2014
Q3 		$42.6M Buy
+118,158
New +$39.6M 0.44% 89

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AGF Investments Inc's REGN Position: Q1 2022 in Review

AGF Investments Inc sold out of Regeneron Pharmaceuticals (REGN) in Q1 2022, closing a stake of 981 shares — an estimated $620K sold.

AGF Investments Inc first reported a position in REGN in Q3 2014 and held it in 16 quarters. The position peaked at $81.2M in Q2 2015. 1,095 funds tracked by Wall St. Rank hold REGN as of Q1 2022.

  • AGF Investments Inc reported no remaining Regeneron Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • AGF Investments Inc sold 981 Regeneron Pharmaceuticals shares in Q1 2022, an estimated $620K.
  • AGF Investments Inc first reported a position in Regeneron Pharmaceuticals in Q3 2014 and held it in 16 quarters.
  • AGF Investments Inc's Regeneron Pharmaceuticals position peaked at $81.2M in Q2 2015.
  • 1,095 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2022.

Based on AGF Investments Inc's 13F filing for Q1 2022, filed 10 May 2022.